πŸ‡ΊπŸ‡Έ FDA
Patent

US 9994600

Prodrug compounds and uses therof

granted A61KA61K31/6615A61K31/662

Quick answer

US patent 9994600 (Prodrug compounds and uses therof) held by Ligand Pharmaceuticals Incorporated expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/6615, A61K31/662, A61K31/663, A61K45/06